Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Hum Vaccin Immunother. 2023 Dec 31;19(1):2177459. doi: 10.1080/21645515.2023.2177459. Epub 2023 Mar 7.
Switching a vaccine for another on a pediatric national immunization program is often done for the betterment of society. However, if poorly implemented, switching vaccines could result in suboptimal transitions with negative effects. A systematic review was conducted to evaluate the existing knowledge from identifiable documents on implementation challenges of pediatric vaccine switches and the real-world impact of those challenges. Thirty-three studies met the inclusion criteria. We synthesized three themes: vaccine availability, vaccination program deployment, and vaccine acceptability. Switching pediatric vaccines can pose unforeseen challenges to health-care systems worldwide and additional resources are often required to overcome those challenges. Yet, the magnitude of the impact, especially economic and societal, was frequently under-researched with variability in reporting. Therefore, an efficient vaccine switch requires a thorough consideration of the added benefits of replacing the existing vaccine, preparation, planning, additional resource allocation, implementation timing, public-private partnerships, outreach campaigns, and surveillance for program evaluation.
在国家免疫计划中,将疫苗从一种切换到另一种通常是为了社会的利益。然而,如果实施不当,疫苗切换可能会导致不理想的过渡,产生负面影响。本系统评价旨在评估可识别文件中关于儿科疫苗切换实施挑战以及这些挑战的实际影响的现有知识。有 33 项研究符合纳入标准。我们综合了三个主题:疫苗供应、疫苗接种计划的实施以及疫苗可接受性。儿科疫苗的切换可能会给全球卫生保健系统带来意想不到的挑战,通常需要额外的资源来克服这些挑战。然而,尤其是在报告方面存在差异,其经济和社会影响的程度经常被低估。因此,有效的疫苗切换需要仔细考虑更换现有疫苗的附加效益,准备、计划、额外资源分配、实施时机、公私合作伙伴关系、推广活动以及针对计划评估的监测。